InMed Pharmaceuticals (INM) Operating Margin (2021 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Operating Margin of 256.36% for Q4 2025, down 5360.0% year-over-year from 4.87% in Q4 2024, and down 57.72% quarter-over-quarter from 162.54% in Q3 2025.
InMed Pharmaceuticals (INM) Operating Margin (2021 - 2025) Analysis & Trends
InMed Pharmaceuticals' Operating Margin history runs 5 years deep, the most recent figure standing at 256.36% for Q4 2025.
- In Q4 2025, Operating Margin fell 5360.0% year-over-year to 256.36%; the TTM figure through Dec 2025 stood at 184.16% (down 2134.0% YoY), while the FY2025 annual figure was 160.77%, up 1750.0% from the prior year.
- Operating Margin for Q4 2025 stood at 256.36%, down from 162.54% in the prior quarter.
- The five-year high for Operating Margin was 20.99% in Q2 2023, with the low at 1626.64% in Q4 2021.
- The 5-year median for Operating Margin is 202.75% (2024), against an average of 420.14%.
- The sharpest annual moves came in 2023 and 2024: Operating Margin soared 124562 bps in 2023, then sank 13755 bps in 2024.
- InMed Pharmaceuticals' Operating Margin stood at 1626.64% in 2021, then jumped by 71 bps to 471.26% in 2022, then jumped by 72 bps to 132.64% in 2023, then sank by 53 bps to 202.75% in 2024, then slipped by 26 bps to 256.36% in 2025.
- Business Quant data shows INM's Operating Margin at 256.36% in Q4 2025, 162.54% in Q3 2025, and 189.17% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.36 Mn | 1.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -256.36% |
| Sep 30, 2025 | -162.54% |
| Jun 30, 2025 | -189.17% |
| Mar 31, 2025 | -151.24% |
| Dec 31, 2024 | -202.75% |
| Sep 30, 2024 | -137.19% |
| Jun 30, 2024 | -158.54% |
| Mar 31, 2024 | -157.28% |
| Dec 31, 2023 | -132.64% |
| Sep 30, 2023 | -296.37% |
| Jun 30, 2023 | -20.99% |
| Mar 31, 2023 | -208.13% |
| Dec 31, 2022 | -471.26% |
| Sep 30, 2022 | -1,114.75% |
| Jun 30, 2022 | -1,266.61% |
| Mar 31, 2022 | -589.94% |
| Dec 31, 2021 | -1,626.64% |